Overview
- Description
iOnctura is a clinical stage biopharmaceutical company focused on delivering innovative cancer treatments to patients with an unmet medical need. It was created in 2017 by Catherine Pickering and Lars van der Veen, two highly experienced professionals with extensive experience in the healthcare industry. The Company was initially founded to develop a portfolio of molecules that have been in-licenced from Cancer Research UK and Merck with the potential to significantly improve the current standard of care in certain cancer treatments. The company is headquartered in the Netherlands, with operations in Amsterdam and Geneva.
- Website
- Founded
2017
- Country
- The Netherlands
- Theme
- Healthcare